Skip to main content
The FDA has approved the first treatment for pseudobulbar affect (PBA).

Dextromethorphan Hydrobromide and Quinidine Sulfate Tablets (Nuedexta™)

The FDA has approved the first treatment for pseudobulbar affect (PBA).